Sabine Fuchs1, Britta Olberg2, Dimitra Panteli3, Matthias Perleth2, Reinhard Busse3. 1. Department of Health Care Management, Berlin University of Technology, Germany. Electronic address: sabine.fuchs@tu-berlin.de. 2. Department of Health Care Management, Berlin University of Technology, Germany; Medical Consultancy Department, Federal Joint Committee (G-BA), Germany. 3. Department of Health Care Management, Berlin University of Technology, Germany.
Abstract
OBJECTIVES: Health Technology Assessment (HTA) of Medical devices (MDs) and MD-based procedures can be challenging due to the unique features and particularities of this group of technologies, such as device-operator interaction. The aim of this study was to (1) clarify, and supplement earlier findings on European HTA institutions' structural, procedural and methodological characteristics with regard to the assessment of MDs and to (2) capture the institutions' perceptions regarding challenges and future trends. METHODS: Semi-structured telephone interviews with 16 representatives from leading European HTA institutions were performed between April and July 2015. Summative and directed content analysis was used for the analysis, which is reported according to the COREQ checklist. RESULTS: Findings from the analysis of the interviews were manifold and partially confirmed what has been noted in the literature (e.g. scarce evidence; identifying relevant studies challenging due to more incremental innovations). Additional themes emerged that can be important for future considerations by HTA institutions and policy-makers alike (e.g. areas for future research; need for specific tools). CONCLUSIONS: The collective opinion of 16 European HTA institutions on MD evaluation could provide ideas to ameliorate the current regulatory situation beyond the modified EU regulation and start broader, more in-depth methodological discussions around the issue. Interviewed experts seem to agree that new approaches such as coverage with evidence development as some countries already introduced could help to overcome the problem with scarce evidence.
OBJECTIVES: Health Technology Assessment (HTA) of Medical devices (MDs) and MD-based procedures can be challenging due to the unique features and particularities of this group of technologies, such as device-operator interaction. The aim of this study was to (1) clarify, and supplement earlier findings on European HTA institutions' structural, procedural and methodological characteristics with regard to the assessment of MDs and to (2) capture the institutions' perceptions regarding challenges and future trends. METHODS: Semi-structured telephone interviews with 16 representatives from leading European HTA institutions were performed between April and July 2015. Summative and directed content analysis was used for the analysis, which is reported according to the COREQ checklist. RESULTS: Findings from the analysis of the interviews were manifold and partially confirmed what has been noted in the literature (e.g. scarce evidence; identifying relevant studies challenging due to more incremental innovations). Additional themes emerged that can be important for future considerations by HTA institutions and policy-makers alike (e.g. areas for future research; need for specific tools). CONCLUSIONS: The collective opinion of 16 European HTA institutions on MD evaluation could provide ideas to ameliorate the current regulatory situation beyond the modified EU regulation and start broader, more in-depth methodological discussions around the issue. Interviewed experts seem to agree that new approaches such as coverage with evidence development as some countries already introduced could help to overcome the problem with scarce evidence.
Authors: Hassane Alami; Pascale Lehoux; Yannick Auclair; Michèle de Guise; Marie-Pierre Gagnon; James Shaw; Denis Roy; Richard Fleet; Mohamed Ali Ag Ahmed; Jean-Paul Fortin Journal: J Med Internet Res Date: 2020-07-07 Impact factor: 5.428
Authors: Pedro Parreira; Liliana B Sousa; Inês A Marques; Paulo Santos-Costa; Sara Cortez; Filipa Carneiro; Arménio Cruz; Anabela Salgueiro-Oliveira Journal: Int J Environ Res Public Health Date: 2020-11-11 Impact factor: 3.390
Authors: Rita Daubner-Bendes; Sándor Kovács; Maciej Niewada; Mirjana Huic; Michael Drummond; Oriana Ciani; Carl Rudolf Blankart; Olena Mandrik; Aleksandra Torbica; John Yfantopoulos; Guenka Petrova; Malwina Holownia-Voloskova; Rod S Taylor; Maiwenn Al; Oresta Piniazhko; László Lorenzovici; Rosanna Tarricone; Antal Zemplényi; Zoltán Kaló Journal: Front Public Health Date: 2021-01-08
Authors: Dario Trapani; Kiu Tay-Teo; Megan E Tesch; Felipe Roitberg; Manju Sengar; Sara C Altuna; Michael J Hassett; Armando A Genazzani; Aaron S Kesselheim; Giuseppe Curigliano Journal: Curr Oncol Date: 2022-08-16 Impact factor: 3.109